Literature DB >> 15982497

Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure.

S G Williams1, L L Ng, R J O'Brien, S Taylor, D J Wright, Y F Li, L B Tan.   

Abstract

AIMS: The extent of exercise intolerance in patients with chronic heart failure (CHF) is dependent on and representative of the severity of heart failure. However, few primary care physicians have direct access to facilities for formal exercise testing. We have therefore explored whether information readily obtainable in the community can reliably predict the functional capacity of patients. METHODS AND
RESULTS: Ninety-six subjects with a wide range of cardiac function (10 healthy controls and 86 CHF patients with NYHA classes I-IV, LVEF 36.9+/-15.2%) were recruited into the study and had resting plasma N-BNP and cardiopulmonary exercise testing to measure peak oxygen consumption (VO2). Significantly higher N-BNP levels were found in the CHF group (299.3 [704.8] fmol/ml, median [IQR]) compared with the healthy control group (7.2 [51.2] fmol/ml), p<0.0001. There were significant correlations between peak VO2 and N-BNP levels (R=0.64, P<0.001), peak VO2 and NYHA class (R=0.76, P=0.001), but no significant correlation was seen between peak VO2 and LVEF (R=0.0788, P=0.33). Multivariate analysis identified plasma N-BNP (P<0.0001) and NYHA class (P<0.0001) as significant independent predictors of peak VO2. Logistic modelling with NYHA class and log N-BNP to predict peak VO2<20 ml/kg/min showed that the area under the curve of receiver-operating-characteristic (ROC) curve was 0.906 (95% CI 0.844-0.968). A nomogram based on the data has been constructed to allow clinicians to estimate the likelihood of peak VO2 to be <20 ml/kg/min for given values of plasma N-BNP and NYHA class.
CONCLUSIONS: By combining information from a simple objective blood test (N-BNP) and a simple scoring of functional status (NYHA), a clinician can deduce the aerobic exercise capacity and indirectly the extent of cardiac dysfunction of patients with CHF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982497     DOI: 10.1016/j.ijcard.2004.05.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?

Authors:  T A Rehn; M Munkvik; P K Lunde; I Sjaastad; O M Sejersted
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  New York Heart Association functional class predicts exercise parameters in the current era.

Authors:  Stuart D Russell; Matthew A Saval; Jennifer L Robbins; Myrvin H Ellestad; Stephen S Gottlieb; Eileen M Handberg; Yi Zhou; Bleakley Chandler
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

3.  Relationship between CCR and NT-proBNP in Chinese HF patients, and their correlations with severity of HF.

Authors:  Zhigang Lu; Bo Wang; Yunliang Wang; Xueqing Qian; Wei Zheng; Meng Wei
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

4.  Acute Cardiorenal Syndrome Type 1 in Patients With Congestive Heart Failure Exacerbations Is Not an Indicator of Poor Outcome and Increased Mortality.

Authors:  Eric Arguelles; Carolina de Elia; Zoran Lasic
Journal:  Cardiol Res       Date:  2014-05-15

5.  A retrospective study on the short-term effect of high-dose spironolactone (80 mg/d) on chronic congestive heart failure.

Authors:  Pan Tao; Tu Zhitao; Liu Jiming
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

6.  Diastolic Dysfunction Contributes to Impaired Cardiorespiratory Fitness in Patients with Lung Cancer and Reduced Lung Function Following Chest Radiation.

Authors:  Georgia K Thomas; Cory R Trankle; Salvatore Carbone; Hayley Billingsley; Benjamin W Van Tassell; Ronald K Evans; Ryan Garten; Elisabeth Weiss; Antonio Abbate; Justin M Canada
Journal:  Lung       Date:  2021-07-08       Impact factor: 3.777

7.  Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity.

Authors:  Beata Zaborska; Grażyna Sygitowicz; Krzysztof Smarż; Ewa Pilichowska-Paszkiet; Andrzej Budaj
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.